Literature DB >> 25031436

Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency.

Nadia Driss1, Fethi Mellouli2, Ahlem Ben Yahia3, Henda Touzi3, Mohamed-Ridha Barbouche4, Henda Triki1, Mohamed Bejaoui2.   

Abstract

Patients with primary immunodeficiencies are usually susceptible to enterovirus infections and have higher risks to develop severe clinical forms. We report a unique description of a boy with major histocompatibility complex class II (MHC-II) deficiency infected by 9 different enterovirus serotypes during a 2-year period, with very mild clinical symptoms, probably due to the immunoglobulin therapy he was receiving.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25031436      PMCID： PMC4313190          DOI： 10.1128/JCM.01122-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  Circulating vaccine-derived polioviruses: current state of knowledge.

Authors:  Olen M Kew; Peter F Wright; Vadim I Agol; Francis Delpeyroux; Hiroyuki Shimizu; Neal Nathanson; Mark A Pallansch
Journal:  Bull World Health Organ       Date:  2004-02-26       Impact factor: 9.408

2.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Enteroviruses in Tunisia: virological surveillance over 12 years (1992-2003).

Authors:  O Bahri; D Rezig; B Ben Nejma-Oueslati; A Ben Yahia; J Ben Sassi; N Hogga; A Sadraoui; H Triki
Journal:  J Med Microbiol       Date:  2005-01       Impact factor: 2.472

4.  Recurrent enterovirus encephalitis: chance or something else?

Authors:  Frankie Wai Tsoi Cheng; Paul K S Chan; Wendy C S Ho; Felix Y W Wong; T F Leung
Journal:  BMJ Case Rep       Date:  2009-06-03

5.  Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

Authors:  O M Kew; R W Sutter; B K Nottay; M J McDonough; D R Prevots; L Quick; M A Pallansch
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Coxsackie B3 virus encephalitis in a patient with agammaglobulinaemia.

Authors:  N T Hertel; F K Pedersen; C Heilmann
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

7.  Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom.

Authors:  Neal A Halsey; Jorge Pinto; Francisco Espinosa-Rosales; María A Faure-Fontenla; Edson da Silva; Aamir J Khan; A D Webster; Philip Minor; Glynis Dunn; Edwin Asturias; Hamidah Hussain; Mark A Pallansch; Olen M Kew; Jerry Winkelstein; Roland Sutter
Journal:  Bull World Health Organ       Date:  2004-01       Impact factor: 9.408

8.  Clinical, immunological and genetic findings of a large tunisian series of major histocompatibility complex class II deficiency patients.

Authors:  Imen Ben-Mustapha; Khaoula Ben-Farhat; Naouel Guirat-Dhouib; Emna Dhemaied; Beya Larguèche; Meriem Ben-Ali; Jalel Chemli; Jihène Bouguila; Lamia Ben-Mansour; Fethi Mellouli; Monia Khemiri; Mohamed Béjaoui; Mohamed-Ridha Barbouche
Journal:  J Clin Immunol       Date:  2013-01-13       Impact factor: 8.317

9.  High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies.

Authors:  Nadia Driss; Imen Ben-Mustapha; Fethi Mellouli; Ahlem Ben Yahia; Henda Touzi; Mohamed Bejaoui; Mohamed Ben Ghorbel; Henda Triki; Mohamed-Ridha Barbouche
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

Review 10.  Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.

Authors:  R E McKinney; S L Katz; C M Wilfert
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr
View more
  8 in total

Review 1.  Clearing Vaccine-Derived Poliovirus Infection Following Hematopoietic Stem Cell Transplantation: a Case Report and Review of Literature.

Authors:  Mohammadreza Shaghaghi; Mona Irannejad; Hassan Abolhassani; Shohreh Shahmahmoodi; Amir Ali Hamidieh; Saeed Soleyman-Jahi; Reza Yazdani; Gholamreza Azizi; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-06-14       Impact factor: 8.317

Review 2.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

Review 3.  Emerging Infections and Pertinent Infections Related to Travel for Patients with Primary Immunodeficiencies.

Authors:  Kathleen E Sullivan; Hamid Bassiri; Ahmed A Bousfiha; Beatriz T Costa-Carvalho; Alexandra F Freeman; David Hagin; Yu L Lau; Michail S Lionakis; Ileana Moreira; Jorge A Pinto; M Isabel de Moraes-Pinto; Amit Rawat; Shereen M Reda; Saul Oswaldo Lugo Reyes; Mikko Seppänen; Mimi L K Tang
Journal:  J Clin Immunol       Date:  2017-08-07       Impact factor: 8.317

4.  Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication.

Authors:  Asghar Aghamohammadi; Hassan Abolhassani; Necil Kutukculer; Steve G Wassilak; Mark A Pallansch; Samantha Kluglein; Jessica Quinn; Roland W Sutter; Xiaochuan Wang; Ozden Sanal; Tatiana Latysheva; Aydan Ikinciogullari; Ewa Bernatowska; Irina A Tuzankina; Beatriz T Costa-Carvalho; Jose Luis Franco; Raz Somech; Elif Karakoc-Aydiner; Surjit Singh; Liliana Bezrodnik; Francisco J Espinosa-Rosales; Anna Shcherbina; Yu-Lung Lau; Shigeaki Nonoyama; Fred Modell; Vicki Modell; Mohamed-Ridha Barbouche; Mark A McKinlay
Journal:  Front Immunol       Date:  2017-06-13       Impact factor: 7.561

Review 5.  SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.

Authors:  Haifa Khemiri; Kaouther Ayouni; Henda Triki; Sondes Haddad-Boubaker
Journal:  Virol J       Date:  2022-09-08       Impact factor: 5.913

6.  Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.

Authors:  Radboud J Duintjer Tebbens; Mark A Pallansch; Kimberly M Thompson
Journal:  BMC Infect Dis       Date:  2015-09-17       Impact factor: 3.090

7.  Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.

Authors:  Nermeen M Galal; Safaa Meshaal; Rabab ElHawary; Eman Nasr; Laila Bassiouni; Humayun Ashghar; Noha H Farag; Ondrej Mach; Cara Burns; Jane Iber; Qi Chen; Aisha ElMarsafy
Journal:  BMC Res Notes       Date:  2018-10-11

8.  Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran.

Authors:  Mohammadreza Shaghaghi; Shohreh Shahmahmoodi; Ali Nili; Hassan Abolhassani; Seyedeh Panid Madani; Ahmad Nejati; Maryam Yousefi; Yaghoob M Kandelousi; Mona Irannejad; Shiva Shaghaghi; Seyed Mohsen Zahraei; Sussan Mahmoudi; Mohammad Mehdi Gouya; Reza Yazdani; Gholamreza Azizi; Nima Parvaneh; Asghar Aghamohammadi
Journal:  Emerg Infect Dis       Date:  2019-11       Impact factor: 6.883
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.